![Avis Budget Group Announces Special Dividend](https://www.servicestrading.net/img/944866d3-e8ad-4618-8959-76255c1f35e2/news-article-8.jpeg?fm=jpg&q=80&fit=max&crop=1080%2C1080%2C420%2C0)
Avis Budget Group Announces Special Dividend
Avis Budget Group's special cash dividend announcement leads to positive market momentum for its stock, with impressive growth throughout the year and ongoing share repurchases.
![EnCore Energy Partners with Boss Energy in $60 Million Uranium Project Deal](https://www.servicestrading.net/img/944866d3-e8ad-4618-8959-76255c1f35e2/news-article-8.jpeg?fm=jpg&q=80&fit=max&crop=1080%2C1080%2C420%2C0)
EnCore Energy Partners with Boss Energy in $60 Million Uranium Project Deal
EnCore Energy forms a strategic partnership with Boss Energy, selling a stake in its uranium project for $60 million. The deal will boost uranium production and support exploration and development drilling activities in Texas.
![Toll Brothers Stock Rises After Beating Earnings Expectations](https://www.servicestrading.net/img/944866d3-e8ad-4618-8959-76255c1f35e2/news-article-8.jpeg?fm=jpg&q=80&fit=max&crop=1080%2C1080%2C420%2C0)
Toll Brothers Stock Rises After Beating Earnings Expectations
Toll Brothers stock rises as Q4 and full-year earnings beat expectations. Lower inflation and mortgage rates expected to drive increased demand for new homes.
![Lululemon Faces Uncertainty as Analysts Lower Stock Ratings](https://www.servicestrading.net/img/944866d3-e8ad-4618-8959-76255c1f35e2/news-article-8.jpeg?fm=jpg&q=80&fit=max&crop=1080%2C1080%2C420%2C0)
Lululemon Faces Uncertainty as Analysts Lower Stock Ratings
Lululemon faces uncertainty as analysts lower stock ratings. Despite gains in stock value, analysts raise concerns about potential price gains and future prospects.
![The Decline of Retail Investors in the Bitcoin Rally](https://www.servicestrading.net/img/944866d3-e8ad-4618-8959-76255c1f35e2/news-article-8.jpeg?fm=jpg&q=80&fit=max&crop=1080%2C1080%2C420%2C0)
The Decline of Retail Investors in the Bitcoin Rally
As the Bitcoin rally continues, there is a decline in retail investors, raising questions about its sustainability. The bull case for Coinbase relies on attracting retail investors.
![NIO Reports Strong Q3 Results](https://www.servicestrading.net/img/944866d3-e8ad-4618-8959-76255c1f35e2/news-article-8.jpeg?fm=jpg&q=80&fit=max&crop=1080%2C1080%2C420%2C0)
NIO Reports Strong Q3 Results
NIO reports strong Q3 results, exceeding expectations and showcasing remarkable growth in deliveries and market share. The company looks to deliver strong Q4 results and stands out among competitors in the Chinese EV industry.
![Review Your Medicare Coverage Before Dec. 7](https://www.servicestrading.net/img/944866d3-e8ad-4618-8959-76255c1f35e2/news-article-8.jpeg?fm=jpg&q=80&fit=max&crop=1080%2C1080%2C420%2C0)
Review Your Medicare Coverage Before Dec. 7
The Medicare annual enrollment period is quickly coming to an end on Dec. 7. Reviewing your coverage can potentially save you money. Here are some tips to consider.
![Bristol Myers Squibb Seeks Expanded Approval for Opdivo in Bladder Cancer Patients](https://www.servicestrading.net/img/944866d3-e8ad-4618-8959-76255c1f35e2/news-article-8.jpeg?fm=jpg&q=80&fit=max&crop=1080%2C1080%2C420%2C0)
Bristol Myers Squibb Seeks Expanded Approval for Opdivo in Bladder Cancer Patients
Bristol Myers Squibb is seeking FDA approval to expand the use of Opdivo, a cancer drug, in bladder cancer patients with limited treatment options. If approved, this regimen would be the first immunotherapy-chemotherapy combination approved...
![Spotify Announces Third Round of Layoffs](https://www.servicestrading.net/img/944866d3-e8ad-4618-8959-76255c1f35e2/news-article-8.jpeg?fm=jpg&q=80&fit=max&crop=1080%2C1080%2C420%2C0)
Spotify Announces Third Round of Layoffs
Shares of Spotify surged after the company announced plans to lay off 1,500 more employees in its third round of job cuts. The restructuring aims to streamline operations and drive profitability, with the stock already experiencing signific...
![Roche Acquires Carmot Therapeutics in $3.1 Billion Deal](https://www.servicestrading.net/img/944866d3-e8ad-4618-8959-76255c1f35e2/news-article-8.jpeg?fm=jpg&q=80&fit=max&crop=1080%2C1080%2C420%2C0)
Roche Acquires Carmot Therapeutics in $3.1 Billion Deal
Roche acquires Carmot Therapeutics for $3.1 billion, gaining access to GLP-1 agonists and solidifying their position in the weight-loss drug market.